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BIOTECHNOLOGY & PHARMACEUTICAL LAW REVIEW
COMMENT
GIVE AND TAKE-BACK: PHARMACEUTICAL
MANUFACTURERS REQUIRED TO DISPOSE OF DRUGS
AT LOCAL LEVEL
ALLIE M. CRAVER *
INTRODUCTION
6.5 million Americans use prescription drugs, such as pain
relievers, stimulants, and tranquilizers, for purposes other than those
prescribed.1 More than 50% of people ages 12 and older who abused
prescription drugs received them from friends or family for free.2
Placed in the wrong hands, unconsumed and unwanted pharmaceuticals expose vulnerable populations, including the elderly and
children, to potential harm by means of ingestion.3 The United States
Food and Drug Administration (FDA) suggest that medications be
disposed by either trashing or flushing. Medications that have been
trashed, which is the predominant method, can still be reused if not
properly mixed with an unpalatable substance. Likewise, flushing
medications can lead to toxins in the water supply.4 By first noting
*

Allie M. Craver, North Carolina Central University School of Law, J.D., expected
2017; Virginia Commonwealth University, M.A. Art History, 2013; East Carolina
University, B.A. Art History, University Honors, magna cum laude, 2011.
1.1DW¶O$VV¶QRI%RDUGV of Pharmacy, The AWARXE Prescription Drug Safety
Program, http://www.awarerx.org (last visited Jun. 16, 2015).
2. Id.
3.Carolyn S. Ma et al, 'UXJ7DNH%DFNLQ+DZDL¶L3DUWQHUVKLS%HWZHHQWKH8QiYHUVLW\RI+DZDL¶L+LOR&ROOHJHRI3KDUPDF\DQGWKH1DUFRWLcs Enforcement Division, 73 Haw. J Med Pub. Health 28, 26-31 (2014).
4.U.S. Food and Drug Admin., Disposal of Unused Medicines, FDA.GOV,
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSa
fely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm. (last
updated Sept. 16, 2015).
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the Environmental Protection $JHQF\¶V (3$ UHFHQWO\SURSRVHGUXOH
concerning pharmaceutical disposal standards, this comment will
explore the current issue of manufacturer-sponsored drug take-back
initiatives implemented by local governments in the United States.
Furthermore, this comment will address the question of whether
pharmaceutical manufacturers should reciprocally give and take-back
prescription drugs within the state of North Carolina.
FEDERAL AGENCIES AND LEGISLATIVE HISTORY
Two federal agencies, the EPA and the Drug Enforcement Agency
(DEA), are responsible for promulgating and enforcing regulations
regarding the disposal of medications. Since the EPA seeks to protect
WKHLQWHJULW\RIWKH8QLWHG6WDWHV¶ZDWHUVWKHDJHQF\KDVWKHDXWKRULW\
to pass regulations concerning environmentally hazardous substances, such as pharmaceuticals.5 Because water treatment facilities in the
United States are not equipped with the technology to filter the active
compounds within prescription drugs, a low concentration of various
pharmaceuticals is present in our water.6 A recent United State
Geological Survey found that 110 of the 139 streams tested in 30
states possessed trace amounts of pharmaceuticals including antibiotics, antidepressants, caffeine, steroids, hypertensive drugs, and reproductive hormones, to name a few.7 With this in mind, the EPA maintains a specific interest in the passing of federal guidelines regarding
drug disposal programs. Furthermore, the EPA favors pharmaceutical
take-back programs over the environmentally damaging alternative
of flushing pharmaceuticals.8
2Q $XJXVW   (3$¶V $GPLQLVWUDWRU VLJQHG WKH SURSRVHG
Management Standards for Hazardous Waste Pharmaceuticals Rule
5.U.S. Environmental Protection Agency, How to Dispose of Medicines Properly,
(2011), http://water.epa.gov/scitech/swguidance/ppcp/upload/ppcpflyer.pdf.
6.See Judith M. Mathias, Untangling Pharmaceutical Waste Requirements, 28 OR
Manager 5 (May 2012), http://www.ormanager.com/wpcontent/uploads/pdf/ORMVo128No5PharmWaste.pdf.
7.Herbert T. Buxton & Dana W. Kolpin, Pharmaceuticals, Hormones, and Other
Organic Wastewater Contaminants in U.S. Streams, U.S. Geologic Survey,
http://toxics.usgs.gov/pubs/FS-027-02/index.html (last updated Aug. 4, 2015).
8.U.S. Environmental Protection Agency, How to Dispose of Medicines Properly,
(2011), http://water.epa.gov?scitech?swguidance/ppcp/upload/ppcpflyer.pdf.
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³3URSRVHG5XOH´ ZKLFKZDVVXEVHTXHQWO\SXEOLVKHGLQWKH)HGHUDO
Register on September 25, 2015.9 Because the Proposed Rule imSDFWV WKHSKDUPDFHXWLFDOLQGXVWU\¶VLQIUDVWUXFWXUHWKH(3$UHFHLYHG
numerous requests to extend the comment period and a public webinar was held on October 13, 2015, to address some of the major concerns.10 As part of the webinar, EPA representatives highlighted six
remaining issues for rulemaking including: (1) pharmaceuticals being
flushed and sewered, and (2) the intersection of EPA & DEA
regulations.11
As one of the key concerns acknowledged by EPA officials, the
flushing and sewering of pharmaceuticals is banned under the
Proposed Rule. The EPA projects that the ban will prevent more than
6,400 tons of flushed and sewered pharmaceuticals from entering the
8QLWHG6WDWHV¶GULQNLQJDQGVXUIDFHZDWHUHDFK year.12 Under the current Resource Conservation and Recovery Act (RCRA), the public
law that provides the framework for the proper management of
hazardous and nonhazardous solid waste, the regulations provide an
exemption for all hazardous waste generated by households, such as
pharmaceuticals, and as such are not subject to RCRA protocols.13
Although flushing is allowed by RCRA regulations, the Proposed
Rule stipulates that as part of a joint effort, the DEA will similarly
ban the flushing and sewering of pharmaceuticals.14 Since toxins in
9. Management Standards for Hazardous Waste Pharmaceuticals, 80 Fed. Reg.
58,014 (proposed Sept. 25, 2015) (to be codified at 40 C.F.R. pts 261, 262, 266,
268, and 273).
10.The comment period for this proposed rule closed on December 24, 2015. Management Standards for Hazardous Waste Pharmaceuticals, 80 Fed. Reg. 68,491
(extension Nov. 5, 2015) (to be codified at 40 C.F.R. pts 261, 262, 266, 268, and
273).
11.U.S. Environmental Protection Agency, Hazardous Waste Pharmaceuticals
Proposed Rule, (2015), http://www.epa.gov/sites/production/files/201510/documents/hw_pharmaceuticals_proposed_rule_3.pdf.
12.U.S. Environmental Protection Agency, Proposed Rule: Management Standards
for Hazardous Waste Pharmaceuticals, (2015),
http://www.epa.gov/hwgenerators/proposed-rule-management-standardshazardous-waste-pharmaceuticals#rule-summary.
13.40 C.F.R. § 261.4(b)(1) (2016).
14.With the proposed rule, the EPA and DEA would join other states with sewer
bans for pharmaceuticals, including: Connecticut, Illinois, New Jersey, and
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the water supply threaten humans, animals, and aquatic ecosystems,
the Proposed Rule seeks to improve compliance and establish
safeguards by dividing the regulations into sector-specific standards,
which clarify the process of reverse distribution and streamline
disposal methods used by healthcare facilities and pharmacies.15
Although there are over 60 proposed changes to the preexisting
regulations, only the pharmaceuticals that are currently considered
hazardous waste under RCRA will be covered.16
Another area of contention addressed during the webinar involves
the convergence of EPA and DEA policies. As the other major
federal agency involved in pharmaceutical regulation, the DEA has
the power to implement strict guidelines concerning drug disposal,
once a drug is identified as a controlled substance.17 As part of its
initiative to promote proper drug disposal, the DEA formulated its
own final ruling on the disposal of controlled substances and has
sponsored the National Take Back Day, a biannual event held in the
spring and fall.18 However, prior to 2010, the DEA lacked clear
guidelines concerning drug disposal.
When Congress passed the Secure and Responsible Drug Disposal
Act of 2010, the legislation provided long-term care facilities, and
ultimate users, individuals originally prescribed the medication, with
additional methods for safe and responsible drug disposal.19 The law
also permitted federal, state, tribal and local law enforcement to
maintain collection receptacles at law enforcement buildings.20
Likewise, law enforcement was permitted to collaborate with private
entities or community groups to sponsor mail-back initiatives and
Washington. Management Standards for Hazardous Waste Pharmaceuticals, 80
Fed. Reg. at 58,014.
15.$FFRUGLQJWRWKHSURSRVHGUXOHWKHWHUP³KHDOWKFDUHIDFLOLWLHV´LQFOXGHVEXWLV
not limited to: hospitals, pharmacies, health clinics, surgical centers, long-term care
facilities, physician offices, veterinary clinics and hospitals, drug compounding
facilities, coroners and medical examiners. Id.
16.For a definition of hazardous waste pharmaceuticals, see 40 C.F.R. § 261.3
(2016).
17.21 C.F.R §1317.01 (2014).
18. Id.
19.Secure and Responsible Drug Disposal Act of 2010, Pub. L. No. 111-273, 124
Stat. 2858.
20. Id.
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hold take-back events.21 Take-back events aim to educate participants
about the potential for abuse of medications, while providing safe,
convenient, and responsible means of disposing of prescription drugs.
Take-back events are typically short in duration and are commonly
held at unregistered locations that are easily accessible to the public.22 Despite expanding the ways ultimate users could dispose of
pharmaceuticals, participation in these programs is not mandatory,
nor could the DEA require an entity to establish or operate a disposal
program.
The following year, the issue of proper drug disposal was one of
IRXU PDMRU SUREOHP DUHDV WDUJHWHG E\ 3UHVLGHQW 2EDPD¶V 
Prescription Drug Abuse Prevention Plan.23 The government plan
proposed that Americans receive access to safe drug disposal methods that, in turn, would protect both their health and the
environment.24 As part of this initiative, in December 2012, the DEA
proposed allowing drug manufacturers, distributors, reverse distributors, and retail pharmacies to establish voluntary collection
receptacles without the presence of an authorized agent. This
proposal was a departure from earlier federal guidelines requiring an
authorized agent be present on-site.25
As this issue received more attention, the FDA updated its
VWDQGDUGV RQ GUXJ GLVSRVDO DQG WKH '($¶V  SURSRVDO ³
SURSRVDO´GHYHORSHGLWVRZQQRQ-retrievable standard of destruction
IRU FRQWUROOHG VXEVWDQFHV %DVHG RQ WKH  SURSRVDO WKH '($¶V
non-retrievable standard would have mandated that a controlled
substance be permanently altered, making it unavailable and
unusable for any purpose.26 Furthermore, the 2013 proposal noted
that simply mixing a substance with coffee grounds or flushing the
21. Id.
22.See Office of National Drug Control Policy, Take-back events frequently are
held at community centers.
23.Office of National Drug Control Policy, Prescription Drug Abuse, The White
House (last accessed Jun. 16, 2015),
https://www.whitehouse.gov/ondcp/prescription-drug-abuse.
24. Id.
25. Id.
26.U.S. Department of Justice: Office of Diversion Control, Disposal Act: General
Public Fact Sheet, (Oct. 17, 2014),
http://www.deadiversion.usdoj.gov/drug_disposal/fact_sheets/disposal_public.pdf.

2016

GIVE AND TAKE-BACK

39

substance would not render the substance non-retrievable. Therefore,
the 2013 proposal advocated for chemical digestion or incineration of
a controlled substance as the proper means of disposal. As noted by
other scholars, this was the first time a federal agency specifically
undermined the long-established, yet environmentally destructive,
method of flushing, mixing, or trashing controlled substances.27
On October 9, 2014, components of the 2013 proposal, including
the preference for mail-back or take-back programs, were
LQFRUSRUDWHG LQWR WKH '($¶V Published Disposal of Controlled
Substances Final Rule. In accordance with the Controlled Substances
Act, the ruling expands those who are permitted to collect controlled
substances through methods such as take-back events, mail-back
programs, and collection receptacle locations.28 As stated in previous
regulations, any DEA registrant, or federal, state, tribunal, or local
law enforcement agency is authorized to collect medications from an
ultimate user or other accepted entity. The final rule further expands
the list of authorized collection registrants to include: manufacturers,
distributors, reverse distributors, narcotic treatment programs, retail
pharmacies, and medical centers with an on-site pharmacy.29
Considering the current collaboration between the EPA and DEA, as
UHIHUHQFHGLQ WKH(3$¶V3URSRVHG5XOHDQGDFFRPSDQ\LQJZHELQDU
further regulations concerning proper drug disposal and voluntary
collection receptacles should be expected.
THE IMPORTANCE OF TAKE-BACK PROGRAMS
Prescription drug abuse is the fastest growing drug problem in the
United States. In order to help stop the non-medical use of
prescription drugs, the DEA has developed programs such as takeback events and mail-back programs to facilitate the handling,
monitoring, and proper disposal of pharmaceuticals. The efficacy of
the DEA-sponsored National Take Back Days is unquestionable: as a

27. Disposal of Controlled Substances, 79 Fed. Reg. 53,520-01 (Sept. 9, 2014) (to
be codified at 21 C.F.R. pts. 1300, 1301, 1304, 1305, 1307, and 1317). See further
in Cook, supra note 34, at 14.
28. Id.
29.21 C.F.R. § 1317.40 (2014).
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result of nine events held over the span of four years, over 2,411 tons,
or 4,823,251 pounds, were returned.30
Although access to these programs may be limited to particular
highly-populated regions, the FDA and DEA suggests that if a
take-back program is not available in an area and there are no
GLVSRVDO LQVWUXFWLRQV OLVWHG RQ D PHGLFDWLRQ¶V ODEHO WKH GUXJ FDQ EH
thrown in the trash after following two essential steps. First, the drug
should be removed from its original container and mixed with an
³XQGHVLUDEOH´VXEVWDQFHVXFKDVGLUWNLWW\OLWWHURUFRIIHHJURXQGV31
Second, the mixture should be placed in a sealable bag or container
to prevent leakage after it is thrown out. Although these trashing
precautions may seem tedious, labels on certain pharmaceuticals
direct that users dispose of the drug by flushing.32 For example, if a
fentanyl patch, an adhesive patch that delivers a powerful pain medicine, is not properly disposed of by flushing, minimal skin contact
can cause severe breathing problems that can lead to death in children, adults, and pets.33 With these issues in mind, establishing a national take-back system would help to prevent non-prescription
holders from accessing dangerous medications, while also reducing
the amount of toxic chemicals in our waters caused by the flushing of
medications.
While take-back and drug disposal programs benefit both
consumers and the environment, the issue of who is responsible for
funding divides the pharmaceutical industry. Recently passed
legislation from Alameda County, California and King County,
Washington requires pharmaceutical manufacturers to fund drug
disposal programs. However, the major controversy now concerns
which entity should be responsible for the costs of these widespread
initiatives.
30.U.S. Drug Enforcement Administration, DEA and Partners Collect 309 Tons of
Pills on Ninth Prescription Drug Take-Back Day, DEA (Nov. 4, 2014),
http://www.dea.gov/divisions/hq/2014/hq110514.shtml.
31.U.S. Food and Drug Admin., Disposal of Unused Medicines, FDA.GOV,
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSa
fely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm. (last
updated Jun. 4, 2015).
32. Id.
33. Id.
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THE ALAMEDA COUNTY ORDINANCE
In December of 2012, Pharmaceutical Research and Manufacturers
of America, the Biotechnology Industry Organization, and the
Generic Pharmaceutical Association filed a lawsuit in the United
States District Court for the Northern District of California
challenging an Alameda County Ordinance as unconstitutional.34
Originally approved by county supervisors in July 2012, the Safe
Drug Disposal Ordinance of Alameda County established a
countrywide, manufacturer-sponsored drug disposal program applied
to all manufacturers that make their drugs available in the county
ZLWKRXWUHVSHFWWRWKHPDQXIDFWXUHU¶VJHRJUDSKLFORFDWLRQ
In Alameda County alone, pharmaceutical companies collect $950
million a year in sales.35 Considering this influx of dispensed
medications, the county spends $330,000 a year to operate approximately 30 medication drop-off sites where consumers can discard
their pills.36 County officials who backed the ordinance claimed drug
companies should bear the cost of disposing their products for the
VDNH RI WKH HQYLURQPHQW DQG WKHLU FRQVXPHUV¶ KHDOWK37 Yet, drug
manufacturers estimated that the annual cost of complying with the
ordinance would be $1.2 million a year DVFRPSDUHGWRWKHFRXQW\¶V
estimate of $330,000.38 Officials for the county argued that the
manufacturers could recoup their costs by raising prices in Alameda
County by one cent for each $10 in sales.39 Given these differences in
opinion, pharmaceutical trade groups filed suit in federal court,
34.Bryan Cook, Comment, H2Whoa?!: An Examination of the Presence of PharPDFHXWLFDOVLQ$PHULFD¶V:DWHUV, 35 J. Legal Med. 211, 16 (2014).
35.Mark Lowery, Federal Court Upholds Groundbreaking Drug-Disposal Law,
Modern Medicine Network (Jun. 16, 2015),
http://drugtopics.modernmedicine.com/drug-topics/news/federal-court-upholdsgroundbreaking-drug-disposal-law?page=0,1.
36. Bob Egelko, $ODPHGD&RXQW\¶V3LRQHHULQJ'UXJ'LVSRVDO/DZ8SKHOGLQ
Federal Court, SFGate (Sept.30,2014),
http://www.sfgate.com/bayarea/article/Alameda-County-s-pioneering-drugdisposal-law-5791624.php.
37. Id.
38. Id.
39.Mark Lowery, Federal Court Upholds Groundbreaking Drug-Disposal Law,
Modern Medicine Network (Jun. 16, 2015).
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alleging an unconstitutional burden on interstate commerce, in
violation of the Commerce Clause.40
The pharmaceutical manufacturer trade groups claimed the
ordinance was unconstitutional because iWZDVD³per se violation of
WKH>&RPPHUFH&@ODXVH´DQGFUHDWHGDQLQKHUHQWO\H[FHVVLYHEXUGHQ
on interstate commerce.41 More specifically, they argued that the
ordinance was an illegal violation of interstate commerce since it
placed local costs on out-of-state producers. The trade groups found
further support from the California Healthcare Institute, who claimed
that these take-back programs may lead to higher priced medications
and that the financial burden was unfairly placed on a single
stakeholder, the manufacturer, rather than spread amongst other
stakeholders, such as local governments, hospitals, pharmacies,
healthcare organizations, and patients.42
In Pharmaceutical Research and Manufacturers of America v.
County of Alameda, the court granted summary judgment in favor of
$ODPHGD &RXQW\ VWDWLQJ WKDW WKH ³>G@HIHQGDQWV KDYH DGHTXDWHO\
shown that the Ordinance serves a legitimate public health and safety
interest, and that the relatively modest compliance costs producers
will incur should they choose to sell their products in the county do
not unduly burden interstate commerce.43 This decision was appealed
to the U.S. Court of Appeals, where, in a 3-0 decision, the Ninth
Circuit DIILUPHG WKH ORZHU FRXUW¶V UXOLQJ 7KH FRXUW KHOG WKDW WKH
FRXQW\¶V RUGLQDQFH GRHV QRW LQIULQJH DJDLQVW UHJXODWH RU
unreasonably burden interstate business since it applied to every
manufacturer supplying in the area.44 The court further added, ³[t]he
fact that the county could run a similar program does not nullify the
40.Pharmaceutical Res. & Manufacturers of Am. v. County of Alameda, 967
F.Supp.2d 1339 (N.D. Cal. Aug. 28, 2013), DII¶G, 768 F.3d 1037, (9d Cir. 2014).
41.Id. at 1344.
42./HWWHUIURP&RQVXHOR+HUQDQGH]9LFH3UHVLGHQW6WDWH*RY¶W$IIDLUV&DOLIRUQLD
Healthcare Inst, to Honorable Nathan A. Miley, Pres. Alameda County Board of
Supervisors (July 9, 2012), http://calpsc.org/admin-document-upload/docdownload/823-california-healthcare-institute-letter-of-opposition-7-9-12. See
Cook, supra note 34, at 232-33.
43.Pharm. Research & Mfrs. & Manufacturers of Am. v. Cnty. County of Alameda,
967 F.Supp.2d 1339, 1346 (N.D. Cal. 2013), DII¶G, 768 F.3d 1037, (9d Cir. 2014).
44.Pharm. Research & Mfrs. & Manufacturers of Am. v. Cnty. County of Alameda,
768 F.3d 1037 (9d Cir. Sept. 30, 2014).
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SURJUDP¶V EHQHILWV«0RUHRYHU HYHQ LI WKH 2UGLQDQFH GLG QRWKLQJ
RWKHUWKDQVDYHWKHFRXQW\PRQH\WKDWLVQRWHTXLYDOHQWWRµQRSXEOLF
EHQHILWV¶³45
Because the pharmaceutical industry has the lobbying power to
prevent similar manufacturer-sponsored drug disposal programs at
WKHVWDWHOHYHO WKHFRXUW¶VGHFLVLRQWR XSKROG WKHVHORFDO RUGLQDQFHV
was decisive in regards to future legislation.46 These judgments
concerning local take-back ordinances may lead to significant action
in both California and Washington state governments. Scholars have
noted that, in 2013, the California legislature considered legislation
modeled in part after the Alameda County ordinance. Likewise, the
Washington legislature introduced a bill requiring manufacturers to
establish a drug take-back program in 2011, which was reintroduced
in 2012.47 :LWK WKH VXFFHVV RI ERWK &DOLIRUQLD¶V DQG :DVKLQJWRQ¶V
localized take-back ordinances, nine state governments have
introduced, but not yet passed, pharmaceutical take-back
legislation.48 If federal courts are willing to uphold drug take-back
programs, perhaps more state or local governments will be inclined
to develop similar legislation.
IMPLEMENTING LOCAL TAKE-BACK PROGRAMS IN NORTH CAROLINA
The EPA, FDA, and DEA highly recommend that individuals take
their expired or unwanted pharmaceuticals to drug take-back programs and disposal sites and only trash drugs if there are no programs
available in the area. Despite the fact that some states readily maintain take-back initiatives, these programs are commonly underfunded
and are primarily available in larger cities.49

45.Id. at 1045 (citing 8QLWHG+DXOHUV$VV¶Q,QFY2QHLGD-Herkimer Solid Waste
Mgmt. Auth., 550 U.S. 330, 346).
46.Mark Lowery, Federal Court Upholds Groundbreaking Drug-Disposal Law,
Modern Medicine Network (Jun. 16, 2015).
47.Caroline Wick, Comment, Mandatory Drug Take-Back Programs: Will They
Survive the Dormant Commerce Clause Challenge?, 27 Tul. Envtl. L.J. 371, 391
(2014).
48.Id. at 391.
49.Id. at 375.
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In North Carolina, the total number of retail prescription drugs
filled at pharmacies during 2014 was 102,887,597.50 Considering the
large quantity of prescription drugs dispensed within the state, there
are only 193 locations, primarily local law enforcement agencies and
police departments, which operate throughout the year as drug
disposal sites.51 These locations are unevenly dispersed throughout
1RUWK &DUROLQD¶V  FRXQWLHV QRW SURSHUO\ SXEOLFL]HG DQG JLYHQ
their settings, could dissuade some consumers from taking action.52
Even though the biannual National Take Back Days raise awareness
for the necessity of proper pharmaceutical disposal, they are too
infrequent, and are too limited to make a significant impact in North
Carolina.53
As part of the National Take Back Day held on September 27,
2014, North Carolina had 74 groups of law enforcement participating
at 119 collection sites, and a total weight of 10,154 pounds of
pharmaceuticals collected.54 &RQVLGHULQJ 9LUJLQLD¶V SDUWLFLSDWLRQ RI
146 groups of law enforcement, 210 collection sites, and a total of
21,872 pounds, North &DUROLQD¶VSHUIRUPDQFHVKRXOGKDYHHTXDOHGRU
VXUSDVVHG 9LUJLQLD¶V HIIRUWV GXH WR 1RUWK &DUROLQD¶V ODUJHU
population.55 Based on the 2014 United States Census, North
Carolina ranks in the top ten for highest state population, with an
estimate of 9,943,964 people.56 During the same National Take Back
Day, other heavily populated states maintained significantly higher
numbers than North Carolina: they had more than 150 groups of law
50.The Henry J. Kaiser Family Foundation, Total Number of Retail Prescription
Drugs Filled at Pharmacies, KFF (Jun. 1, 2015), http://kff.org/other/stateindicator/total-retail-rx-drugs/?state=NC.
51.N.C. Dept. of Ins., North Carolina Operation Medicine Drop, N.C. D.O.I. (last
visited Feb. 13, 2016), https://apps.ncdoi.net/f?p=102:1:8854982067030::NO:::.
52. Id.
53. Id.
54.Drug Enforcement Administration, Diversion Control Program: National Take
Back Day, September 27, 2014, DEA (Sept. 27, 2014),
http://www.dea.gov/divisions/hq/2014/hq110514.pdf.
55. Id.
56.U.S. Census Bureau, American Fact Finder: Community Facts, (last visited Jun.
16, 2015),
http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=b
kmk.
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enforcement, more than 200 collection sites, and the majority had
double the weight of pharmaceuticals collected.57 Going forward,
supporters of drug disposal programs in North Carolina should not be
concerned with its ranking or numbers in regards to the National
Take Back Days. Adhering to their newly implemented rule, the
DEA will not continue to sponsor nationwide take-back events in
order to prevent competition with local efforts conducted in
accordance with the new regulations.58 Realizing the impressive
national total of 617,150 pounds, or 309 tons, from this past National
Take Back Day and the call to action for which it creates, the
question remains as to how successful localized efforts will be
compared to those sponsored by the DEA.
8QGHU 1RUWK &DUROLQD¶V 2SHUDWLRQ 0HGLFLQH 'URS D VWDWHZide
event sponsored by Attorney General Roy Cooper, the State Bureau
of Investigation, local sheriffs and police, the North Carolina
Department of Insurance, and the DEA, approximately 61 million
doses of pharmaceuticals were properly disposed of in a span of five
years.59 During the week-long event held in March 2014, more than
eight million doses of old prescription drugs and over-the-counter
drugs were collected. However, as the collection results were tallied,
it became apparent that the larger county police departments were
responsible for the majority of the collections.60 Similarly, statewide
efforts should be made to establish permanent and diversified
location sites, which in turn would prompt higher totals throughout
the year.
However, initiating a local take-back program is not an easy task.
One of the major obstacles concerning take-back initiatives is the
amount of public education required to foster a successful event.
Some earlier take-back events permitted only controlled substance
disposal because the FDA and DEA maintained strict regulations on
which drugs fell under the classification as well as those which could
57.Drug EnI¶W$GPLQsupra note 50.
58.86'HS¶WRI-XVWLFH'UXJ(QI¶W$GPLQsupra note 30.
59.N.C. Dept. of Justice, More Than 8 Million Pills Turned in During Operation
Medicine Drop, N.C. D.O.J. (Mar. 27, 2014),
http://www.ncdoj.gov/getdoc/50606996-0e97-4ac3-9f0f-9539f056c2c3/More-than8-million-pills-turned-in-during-Operati.aspx.
60. Id.
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be mixed.61 Because of the costs of separating medications, today,
most take-back events allow for the comingling of controlled and
non-controlled substances, as seen in Operation Medicine Drop.62
Likewise, this comingling ensures the proper disposal of all
pharmaceuticals in a non-retrievable fashion. However, sponsors of
these events may specify that only controlled substances will be
accepted and could offer a separate receptacle designated for
non-controlled substances. Regardless of the classification, all of the
collected pharmaceuticals should be securely stored or transferred
until rendered non-retrievable. Becoming non-retrievable by
incineration, the collected drugs will be incapable of being re-sold,
repackaged, or re-dispensed.63
Another issue concerning the take-back event is safety. The DEA
believes that it is imperative to establish active law enforcement
participation for the safety of event participants and the community.64
Because of the low physical security at such locations, the presence
of law enforcement will help deter theft and prevent the diversion of
controlled substances. Since there is not a national requirement for
pharmaceuticals to be in their original packaging, nor is there a
requirement that anyone provide personal information about
themselves, their prescription, or their physician, some organizations
are concerned that these events may incite greater crime.65
Although establishing a take-back event could be seen as an
arduous task for a local organization, some alternative groups within
North Carolina could help expand the effort. As noted by other
scholars, the Veterans Health Administration (VA) medical system is
the largest healthcare network in the United States and should be
utilized in the expansion of local and statewide pharmaceutical takeback programs.66 1RWLQJ WKH 9$¶V H[WHQVLYH QHWZRUN RI  FDUH
locations, its integrated medical system, and its on-site pharmacies
61.86'UXJ(QI¶W$GPLQsupra note 50.
62.1&'HS¶WRI-XVWLFHsupra note 55.
63.86'HS¶WRI-XVWLFH'UXJ(QI¶W$GPLQsupra note 30.
64. Id.
65. Id.
66.Tamika Brown, Implications for a Drug Take Back Program in the Veterans
Affairs Healthcare System (2014) (M.A. of Environmental Assessment thesis,
North Carolina State University).
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reaching 8.76 million veterans annually, the VA has the resources,
facilities, and patrons to become a major benefactor.67 Likewise,
JLYHQ WKH '($¶V UHFHQW UXOLQJ SKDUPDFLHV KRVSLWDOV DQG RWKHU
medical facilities are now able to purchase containers for the disposal
of pharmaceuticals.
Yet, some pharmacies are wary of forming partnerships with local
take-back programs. According to the American Pharmacist
Association, there are two major concerns: cost and liability.68 Some
American companies offering this disposal service price a set of 50
envelopes at $249 plus shipping and handling along with the
additional charge of state tax.69 Furthermore, pharmacies would incur
the expenses of providing permanent receptacles, fees for
transportation and disposal, as well as outreach and publicity
materials. With respect to liability, the DEA ruling mandates that an
employee be present at the receptacle site; therefore, the question of
who would be liable if the receptacles are tampered with or stolen
remains unanswered.70
Quite possibly, the easiest solution is to follow the examples set by
Alameda County, California and King County, Washington. Having
noted the successful ordinances in both locations, North Carolina
state and local governments should devise a similar approach because
drug manufacturers have the finances, accessibility, and manpower to
assist disposal programs.
Located in North Carolina, The Research Triangle Park (RTP) is
the largest research park in the country and is home to more than 200
companies in the fields of micro-electronics, telecommunications,
biotechnology,
chemicals,
environmental
sciences,
and
71
pharmaceuticals. These RTP industries invest more than $296
million in research and development in North Carolina, which is
double the average investment for other national innovation clusters,
and could easily help fund, publicize, and supervise a drug disposal
67. Id.
68.Desiree Hodges, Prescription Take-Back Programs 23 (March 26, 2015)
(PharmD. Candidate 2015 thesis, New Mexico Pharmacists Association).
69. Id.
70. Id.
71.The Research Triangle Park, About Us, RTP (last visited Jun. 16, 2015),
http://www.rtp.org/about-us/.
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program within the state.72 If RTP manufacturers challenge whether
an ordinance could be successful long term, proponents of take-back
programs should cite the British Columbia Waste Management Act of
1997.73 The act fostered the Post-Consumer Pharmaceutical
Stewardship Association, a group that placed collection bins in
pharmacies throughout the province, and facilitated the transfer and
incineration of collected pharmaceuticals.74 The association, fully
funded by pharmaceutical manufacturers and brand owners, helped
collect 4,500 kilograms of medications from 75% of pharmacies in
the area in 2000.75 Only ten years later, 60,500 kilograms were
collected from 96% of the area pharmacies. According to researchers,
if the same amount of Americans participated in a similar
manufacturer-sponsored disposal program, more than 5.4 million
kilograms, or 12 million pounds, of pharmaceuticals would be
collected.76 Advocates of the drug take-back events should extend
their North Carolina campaign to RTP since the site offers plentiful
resources as well as a diverse field of related industries. In North
Carolina, a manufacturer-sponsored drug take-back ordinance should
be implemented to ensure that both urban and rural residents have
access to facilities that can properly and safely dispose of unused
pharmaceuticals.
CONCLUSION
Drug take-back initiatives have the potential to modernize the
system of pharmaceutical distribution. Medical professionals could
use the data collected from unused and overprescribed medications to
streamline the healthcare system, which would have a positive impact
on the environment and the overall health of society. If
pharmaceuticals were prescribed as based on these findings, it is less
likely they would be improperly disposed or consumed.
Coincidentally, the Director of the Office of National Drug Control
Policy projects a similar future of pharmaceutical disposal that will
72. Id.
73.See Cook, supra note 34, at 16.
74. Id.
75. Id.
76. Id.
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EHFRPH³VHFRQG-nature to most Americans, in much the same way as
SURSHU DQG UHVSRQVLEOH UHF\FOLQJ RI DOXPLQXP FDQV KDV EHFRPH´77
$V FODULILHG E\ WKH (3$¶V recently Proposed Rule, pharmaceutical
waste poses a threat to the environment, to consumers, and to
corporations responsible for their manufacture. Given the decisions
in California and Washington requiring drug manufacturers to
sponsor local take-back programs, many other counties and districts
in North Carolina, and throughout the United States, could adopt
similar ordinances. In regards to the current state of pharmaceutical
development, these impending costs on pharmaceutical
manufacturers may lead to raised prices and stricter guidelines
regarding drug manufacture and distribution. However, upon
realizing the health benefits of drug disposal programs, it is all a
matter of give and take.

77.See Wick, supra note 47, at 391.

